MiMedx Group Inc

Healthcare · Biotechnology

4.70$ -0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

MiMedx Group Inc (MDXG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 281 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MDXG
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	189	239	222	230	244	264	270	291	319	343	309	281
Current Assets	155	164	139	154	172	192	200	221	254	277	240	205
Cash	81	82	48	69	89	104	106	119	142	166	160	136
Cash & Short-Term Investments	81	82	48	69	89	104	106	119	142	166	160	136
Receivables	49	54	57	53	54	56	62	69	78	76	46	41
Inventory	19	21	24	25	24	24	24	25	27	25	26	21
Goodwill	19	19	19	19	19	19	19	19	19	19	19	19
Intangible Assets	5.4	5.3	13	12	11	12	11	12	11	14	13	12
Total Liabilities	188	96	66	62	63	71	68	74	80	86	66	65
Current Liabilities	44	46	42	40	42	46	43	50	58	64	45	38
Short-Term Debt	–	1.5	1.0	1.0	1.0	2.3	1.1	1.3	1.4	2.8	1.5	1.5
Accounts Payable	9.2	9.0	9.7	7.6	6.9	7.4	8.9	8.5	11	15	11	8.3
Long-Term Debt	49	48	18	18	18	18	18	17	17	16	16	16
Shareholders' Equity	1.3	143	156	168	181	193	203	217	239	257	243	216
Retained Earnings	-187	-134	-124	-107	-99	-91	-84	-75	-58	-43	-54	-68
Shares Outstanding	119	148	150	149	148	149	150	149	150	150	148	148

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings